Semin Liver Dis 2007; 27(1): 122-127
DOI: 10.1055/s-2007-967203
DIAGNOSTIC PROBLEMS IN HEPATOLOGY

Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Hepatocellular Carcinoma Associated with an Atypical Presentation of Wilson's Disease

Ruliang Xu1 , Moueen Bu-Ghanim1 , M. Isabel Fiel1 , Thomas Schiano2 , 3 , Emil Cohen4 , Swan N. Thung1
  • 1The Lillian and Henry M. Stratton-Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York
  • 2Department of Internal Medicine, Division of Hepatology, The Mount Sinai Medical Center, New York, New York
  • 3Recanati/Miller Transplantation Institute, The Mount Sinai Medical Center, New York, New York
  • 4Department of Radiology, The Mount Sinai Medical Center, New York, New York
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
12. Februar 2007 (online)

Wilson's disease (WD) is a rare autosomal recessive metabolic disorder with an incidence of 1:40,000.[1] The WD gene is located on chromosome 13 and codes for a copper transporting P-type ATPase-ATP7B.[2] [3] Mutations of the WD gene cause impaired biliary copper excretion, resulting in copper accumulation in many vital organs, including liver, central nervous system, and cornea. Patients may therefore develop cirrhosis, neurological manifestations, and Kayser-Fleischer rings. A fair number of patients, however, may have only hepatic manifestations, and among these patients with liver disease some have normal laboratory results, such as normal levels of serum ceruloplasmin and 24-hour urine copper excretion.[4] [5] In this subset of patients the diagnosis of WD becomes a challenge, and subsequent management is problematic.

The development of hepatocellular carcinoma (HCC) in WD is reported to be a rare but deadly complication. In contrary to early observations that copper accumulation may have a protective effect on hepatocarcinogenesis,[6] [7] recent evidence suggests that accumulation of copper in the liver is a risk factor for HCC.[4] [8] To date, there have been at least 20 reported cases of HCC associated with well-established WD.[4] [6] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] These tumors have been treated either surgically or with chemoembolization, both showing variable results.

Herein we report an unusual case of HCC being the first manifestation of undiagnosed WD; the HCC was successfully treated with liver transplantation and the diagnosis of WD was made upon review of the liver explant.

REFERENCES

  • 1 Frydman M. Genetic aspects of Wilson's disease.  J Gastroenterol Hepatol. 1990;  5 483-490
  • 2 Tanzi R E, Petrukhin K, Chernov I et al.. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene.  Nat Genet. 1993;  5 344-350
  • 3 Vrabelova S, Letocha O, Borsky M, Kozak L. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease.  Mol Genet Metab. 2005;  86 277-285
  • 4 Kumagi T, Horiike N, Michitaka K et al.. Recent clinical features of Wilson's disease with hepatic presentation.  J Gastroenterol. 2004;  39 1165-1169
  • 5 Riordan S M, Williams R. The Wilson's disease gene and phenotypic diversity.  J Hepatol. 2001;  34 165-171
  • 6 Wilkinson M L, Portmann B, Williams R. Wilson's disease and hepatocellular carcinoma: possible protective role of copper.  Gut. 1983;  24 767-771
  • 7 Kamamoto Y, Makiura S, Sugihara S, Hiasa Y, Arai M. The inhibitory effect of copper on DL-ethionine carcinogenesis in rats.  Cancer Res. 1973;  33 1129-1135
  • 8 Masaki T, Shiratori Y, Rengifo W et al.. Hepatocellular carcinoma cell cycle: study of Long-Evans cinnamon rats.  Hepatology. 2000;  32 711-720
  • 9 Iwadate H, Ohira H, Suzuki T et al.. Hepatocellular carcinoma associated with Wilson's disease.  Intern Med. 2004;  43 1042-1045
  • 10 Kamakura K, Kimura S, Igarashi S, Fujiwara K, Toshitsugu O. [A case of Wilson's disease with hepatoma (author's transl].  Nippon Naika Gakkai Zasshi. 1975;  64 232-238
  • 11 Buffet C, Servent L, Pelletier G, Rondot P, Etienne J P. [Hepatocellular carcinoma in Wilson's disease].  Gastroenterol Clin Biol. 1984;  8 681-682
  • 12 Madden J W, Ironside J W, Triger D R, Bradshaw J P. An unusual case of Wilson's disease.  Q J Med. 1985;  55 63-73
  • 13 Guan R, Oon C J, Wong P K, Foong W C, Wee A. Primary hepatocellular carcinoma associated with Wilson's disease in a young woman.  Postgrad Med J. 1985;  61 357-359
  • 14 Polio J, Enriquez R E, Chow A, Wood W M, Atterbury C E. Hepatocellular carcinoma in Wilson's disease: case report and review of the literature.  J Clin Gastroenterol. 1989;  11 220-224
  • 15 Cheng W S, Govindarajan S, Redeker A G. Hepatocellular carcinoma in a case of Wilson's disease.  Liver. 1992;  12 42-45
  • 16 Kumagi T, Horiike N, Abe M et al.. Small hepatocellular carcinoma associated with Wilson's disease.  Intern Med. 2005;  44 439-443
  • 17 Lygren T. Hepatolenticular degeneration (Wilson's disease) and juvenile cirrhosis in the same family.  Lancet. 1959;  1 275-276
  • 18 Girard P F, Vachon A, Tommasi M, Paliard P, Rochet M, Barthe J. Hepatolenticular degeneration and primary cancer of the liver.  Lyon Med. 1968;  219 1395-1400
  • 19 Terao H, Itakura H, Nakata K et al.. An autopsy case of hepatocellular carcinoma in Wilson's disease [in Japanese].  Acta Hepatol Jpn. 1982;  23 439-445
  • 20 Imhof M, Lehmann L, Wasmer H P. Morbus Wilson end primares Leberzaell-Karzinom.  Munch Med Wochenschr. 1985;  127 1001-1002
  • 21 Agret F, Vallet-Pichard A, Landau A, Carnot F, Pol S. [Late presentation of Wilson's disease as cirrhosis complicating hepatocellular carcinoma].  Gastroenterol Clin Biol. 2003;  27 130-131
  • 22 Walshe J M, Waldenstrom E, Sams V, Nordlinder H, Westermark K. Abdominal malignancies in patients with Wilson's disease.  Q J Med. 2003;  96 657-662
  • 23 Savas N, Canan O, Ozcay F et al.. Hepatocellular carcinoma in Wilson's disease: a rare association in childhood.  Pediatr Transplant. 2006;  10 639-643
  • 24 Miyamura H, Nakanuma Y, Kono N. Survey of copper granules in liver biopsy specimens from various liver abnormalities other than Wilson's disease and biliary diseases.  Gastroenterol Jpn. 1988;  23 633-638
  • 25 Goldfischer S, Popper H, Sternlieb I. The significance of variations in the distribution of copper in liver disease.  Am J Pathol. 1980;  99 715-730
  • 26 Ishida M, Nakagawara G, Imamura Y, Fukuda M. Iron and copper deposition in chronic active hepatitis and liver cirrhosis: pathogenetic role in progressive liver cell damage.  Eur J Histochem. 1995;  39 221-236
  • 27 Harada M. Wilson disease and hepatocellular carcinoma.  Intern Med. 2004;  43 1012-1013
  • 28 Suriawinata A, Xu R. An update on the molecular genetics of hepatocellular carcinoma.  Semin Liver Dis. 2004;  24 77-88
  • 29 Haberal M, Moray G, Karakayali H et al.. Liver transplantation for Wilson's cirrhosis: one center's experience.  Transplant Proc. 1999;  31 3160-3161
  • 30 Macedo G, Maia J C, Gomes A et al.. Wilson's disease: challenging diagnosis, management, and liver transplantation timing.  Transplant Proc. 2000;  32 2668
  • 31 Wang X H, Cheng F, Zhang F et al.. Living-related liver transplantation for Wilson's disease.  Transpl Int. 2005;  18 651-656

Ruliang XuM.D. Ph.D. 

The Lillian and Henry M. Stratton-Hans Popper Department of Pathology, The Mount Sinai Medical Center, One Gustave L. Levy Place

1190 Fifth Avenue, New York, NY 10029

    >